&nbsp;

HPV_Postcard_Tamil.pdf

New

Aug 2025

Document

HPV_Postcard_Tibetan.pdf

New

Aug 2025

Document

HPV_Postcard_Ukrainian.pdf

New

Aug 2025

Document

HPV_Postcard_Urdu.pdf

New

Aug 2025

Document

HPV_Postcard_Vietnamese.pdf

New

Aug 2025

Regimen

CISPPACL+PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Primary Advanced or Recurrent Endometrial Carcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPGEMC+DURV

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Curative

Drugs Used:

durvalumab (Compassionate),

gemcitabine,

CISplatin

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISP(RT)+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded),

CISplatin

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPGEMC(W)+DURV

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Curative

Drugs Used:

durvalumab (Compassionate),

gemcitabine,

CISplatin

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CRBP(RT-3W)+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded),

CARBOplatin